Last Updated on December 31, 2023 by The Health Master
The US Food and Drug Administration (USFDA) declined to approve Verrica Pharma’s drug for the treatment of a viral skin disease known as molluscum contagiosum, the company said recently.
The disease is caused by a pox virus and leads to skin-toned to pink-colored lesions that can cause pain, inflammation, itching and bacterial infection.
While the lesions usually go away within a year without scarring, some cases could take a lot more time.
There are currently no approved treatments in the US for the condition.
The USFDA denied approval for Verrica’s drug VP-102 due to deficiencies identified at Sterling Pharmaceuticals Services, a contract manufacturer that produces Verrica’s bulk solution drug product, during a general re-inspection, which resulted in an Official Action Indicated (OAI) status.
An OAI is the USFDA’s most serious category of violation, and regulatory experts say it could lead to a prohibition on the sale of drugs from a facility, if not addressed.
Verrica said it had been told that internal policy is preventing the health regulator from “communicating the label and approving the New Drug Application (NDA) when a contract manufacturer is placed on OAI status.
None of the issues identified by the USFDA during its re-inspection were specific to the manufacturing of VP-102, Verrica said in its statement.
The health regulator had declined Verrica’s marketing application for the drug last year, citing general quality issues at one of the company’s third-party manufacturing facilities.
USFDA lifts hold on Covaxin’s clinical trials
Govt allows import of Oxytocin Reference Standards for test & analysis
USFDA issues final approval to Alembic for Pirfenidone tablets
Hyderabad Pharma City to be part of new master plan
These important medical drugs are found in plants
De-addiction center raided by joint team of FDA Haryana & Police: HM
Drug recall: Over 10,000 bottles of generic Anti-depression Drug recalled
Financial aid to the family of late Sh. Sudip Ganguly, Drug Inspector West Bengal
Govt adds psoriasis drug Acitretin under Schedule H of Drugs Rules
Latest Notifications regarding Pharmaceuticals
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
